BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAK7. A total of 34 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $183,557 | +3.2% | 2,074,551 | +1.1% | 0.32% | +9.8% |
| Q2 2023 | $177,808 | -11.2% | 2,051,316 | -0.4% | 0.29% | -17.3% |
| Q1 2023 | $200,251 | -7.4% | 2,059,347 | -1.5% | 0.35% | -19.9% |
| Q4 2022 | $216,269 | -99.9% | 2,089,754 | -4.6% | 0.43% | +15.2% |
| Q3 2022 | $185,686,000 | -1.5% | 2,190,467 | -3.7% | 0.38% | +7.4% |
| Q2 2022 | $188,489,000 | +7.3% | 2,274,521 | -0.1% | 0.35% | +48.9% |
| Q1 2022 | $175,618,000 | -13.7% | 2,277,794 | -1.2% | 0.24% | -4.5% |
| Q4 2021 | $203,602,000 | +8.5% | 2,304,490 | -5.1% | 0.25% | +6.5% |
| Q3 2021 | $187,590,000 | -5.0% | 2,427,099 | +2.6% | 0.23% | -3.3% |
| Q2 2021 | $197,478,000 | – | 2,366,716 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADVENT CAPITAL MANAGEMENT /DE/ | 70,652,000 | $71,212,000 | 1.38% |
| SHENKMAN CAPITAL MANAGEMENT INC | 14,821,000 | $14,947,000 | 1.36% |
| AQR Arbitrage LLC | 21,650,000 | $21,800,000 | 0.61% |
| Worth Venture Partners, LLC | 708,000 | $714,000 | 0.27% |
| LOOMIS SAYLES & CO L P | 2,366,716 | $197,478,000 | 0.24% |
| MACKAY SHIELDS LLC | 24,500,000 | $24,670,000 | 0.23% |
| CAMDEN ASSET MANAGEMENT L P /CA | 2,500,000 | $2,505,000 | 0.10% |
| PALISADE CAPITAL MANAGEMENT, LP | 2,429,000 | $2,442,000 | 0.06% |
| Alberta Investment Management Corp | 5,500,000 | $5,545,000 | 0.05% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 1,900,000 | $1,913,000 | 0.04% |